Pharmafile Logo
Pharmafocus logo
Advanced Search
Denny Bros Open day Pharmafile

Denny Bros Pharmaceutical Open Day Highlights the Need for Clearer and More Accurate Labelling

May 21, 2014

News
Press release
bms_close_logo

BMS and AbbVie get FDA lift

May 21, 2014
Research and Development, Sales and Marketing AbbVie, BMS, FDA, elotuzumab, multiple, myeloma

Bristol-Myers Squibb and AbbVie are celebrating after receiving breakthrough designation status from the US regulator for their investigational medicine elotuzumab …

News
Sovaldi pack shot

Gilead price lambasted by US health insurers

May 21, 2014
Medical Communications, Sales and Marketing Gilead, Incivek, Victrelis, hepatitis C, sovaldi

Gilead’s new hepatitis C pill Sovaldi is coming under more pressure in the US as health insurers hit out at …

News
GSK logo

GSK’s Arzerra fails in lymphoma

May 21, 2014
Research and Development, Sales and Marketing Arzerra, GSK, Genmab, non-Hodgkin lymphoma

News
babs_joly

Rebranding and personnel news for Discovery London

May 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing holy, london discovery, medics, publicis

Publicis Healthcare-owned med comms firm Medicus International has been rebranded as Discovery London. Barbara Joly is the general manager of …

Appointment

GAVI vaccine group call for $7.5 billion funding

May 20, 2014
Medical Communications, Sales and Marketing GAVI Alliance, Vaccine, WHO, rotavirus vaccine

The GAVI Alliance is calling on donors to back ambitious plans to immunise an additional 300 million children against potentially …

News

Medicus International rebrands as Discovery London

May 20, 2014
Medical Communications, Sales and Marketing Medicus International, Publicis Healthcare

Publicis Healthcare-owned medical communications group Medicus International has rebranded to Discovery London, thereby officially joining the Discovery worldwide brand. Discovery …

News
Janssen logo

Europe approves Janssen’s hep C drug Olysio

May 20, 2014
Research and Development, Sales and Marketing Janssen, hepatitis C, sovaldi

Janssen-Cilag International’s Olysio has been given marketing authorisation in the European Union for the treatment of adults with hepatitis C …

News
Abbott logo

Abbott makes Latin America move

May 20, 2014
Manufacturing and Production, Sales and Marketing AbbVie, Abbott, CFR, Chile, pharmerging

Abbott is to pay around $2.9 billion to secure its foothold in Latin America, buying Chile’s CFR Pharmaceuticals to double …

News

Boehringer and InterMune data on IPF drugs impress

May 19, 2014
Research and Development, Sales and Marketing Boehringer Ingelheim, InterMune, idiopathic pulmonary fibrosis

Two new medicines for a generally fatal lung disease, known as idiopathic pulmonary fibrosis and made by Boehringer and InterMune, …

News
ownfone

Braille phone launched by UK developer

May 19, 2014
Manufacturing and Production, Medical Communications, Research and Development Apple

British technology firm OwnFone has launched what it says is the first commercially available Braille phone. The device, which shares …

News
Novartis logo

Novartis agrees Gleevec patent deal

May 19, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent

Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …

News
AstraZeneca logo

AstraZeneca rejects Pfizer’s ‘final offer’

May 19, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, R&D, UK, science, takeover

AstraZeneca has this morning rejected a new bid from Pfizer that could have seen the US giant pay £69 billion …

News
Ian Read

Science left behind in Pfizer-AstraZeneca saga

May 18, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, MPs, Pfizer, Wellcome Trust, science

With all the posturing, debates and endless comment on the commercial aspects of a $106 billion deal between Pfizer and …

News
Pfizer New York HQ

Pfizer to submit breast cancer drug

May 18, 2014
Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib

Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …

News

Merck sells Colorado biologics plant to KBI

May 18, 2014
Manufacturing and Production KBI, Merck, manufacturing

Merck & Co has swung the axe over its M&P operations again – this time for its biologics plant in …

News
Lord Maurice Saatchi

Clinical evidence revisited

May 18, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …

Feature
FDA logo

Heartbreak for Novartis as FDA rejects drug

May 18, 2014
Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

News
AstraZeneca's Cambridge Biomedical campus

AstraZeneca signs UK research deal

May 16, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …

News
roche_logo_shadow_7

Roche gets oncology boost with cancer vaccine

May 16, 2014
Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026